The Institute of Cancer Research, London is one of the world’s most influential cancer research organisations. We are a UK charity and member institution of the University of London.
The first patients are set to receive a new drug, targeting the HSF1 pathway, as part of a clinical trial.
The research areas that could revolutionise prostate cancer treatment in years to come.
Advances in our research are helping men live longer and with a better quality of life. With your support, we will continue to find new ways to defeat prostate cancer – so more men will survive this disease.
Teams of biologists, chemists and computational scientists design new drugs to selectively attack tumours.
We will comprehend the full complexity of cancer by harnessing the power of new technologies and Big Data.
We will take on the challenge of cancer’s complexity, evolution and drug resistance through the discovery of innovative new approaches to cancer treatment.
We will move a step closer to cure by bringing personalised treatments into the clinic and developing them for patients.
We will deliver better outcomes and quality of life for patients by establishing innovative treatments, diagnostics and prevention strategies as part of routine healthcare.
The ICR has been recognised with a prestigious Queen’s Anniversary Prize for its world-leading research in cancer drug discovery.
Help us continue to find new ways to defeat prostate cancer – so more men will survive this disease.
See what life is like as a student at The Institute of Cancer Research, the UK’s leading academic research centre.
We always want to hear from people who have a cancer story to share.
Get in touch and help raise awareness of our research.
The ICR conducts research into many different types of cancer, from common cancers such as breast and prostate, to rarer diseases such as rhabdomyosarcoma.
The ICR and Imperial College London are working together to open up new frontiers in cancer research.
Search is our supporter newsletter. Subscribe to read our latest news and research, as well as interviews with our world-leading scientists and clinicians.
Our state-of-the-art drug discovery centre will enable us to create more and and better cancer drugs
Rising to the challenge: meet one of our researchers applying expertise in breast cancer research to make gains in childhood cancer
How new guidelines are ushering in a new era for breast cancer clinical trials
@VOWWholesale Thank you for doing this for the ICR! 🎊❤️
RT @cancerBRC: Join us this March for our 'What does the future hold for #breastcancer?' event to discover the impact that @royalmarsdenNHS…
RT @BreastCancerNow: We are hosting #UKIBCS for researchers, healthcare professionals and patient advocates on 24-25 January.